Kurozumi, S., Inoue, K., Matsumoto, H., Fujii, T., Horiguchi, J., Oyama, T., . . . Shirabe, K. (2019). Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer. Sci Rep.

Kurozumi, Sasagu, Kenichi Inoue, Hiroshi Matsumoto, Takaaki Fujii, Jun Horiguchi, Tetsunari Oyama, Masafumi Kurosumi, and Ken Shirabe. "Prognostic Utility of Tumor-infiltrating Lymphocytes in Residual Tumor After Neoadjuvant Chemotherapy With Trastuzumab for HER2-positive Breast Cancer." Sci Rep 2019.

Kurozumi, Sasagu, et al. "Prognostic Utility of Tumor-infiltrating Lymphocytes in Residual Tumor After Neoadjuvant Chemotherapy With Trastuzumab for HER2-positive Breast Cancer." Sci Rep 2019.